Enzymatic DNA Synthesis Market to Reach USD 2.86 Billion by 2034 | CAGR: 26.7%

The global enzymatic DNA synthesis market is attracting interest from biotechnology researchers and developers of genetic medicines. The market value stood at USD 0.34 billion in 2025. It is expected to reach USD 2.86 billion by 2034. The growth rate of the market between 2026 and 2034 is projected at a CAGR of 26.7%. The technology involves using enzymes to construct DNA sequences. It is currently being researched as an alternative to chemical-based DNA synthesis processes.

Research Funding Supports New Synthesis Methods

The production of DNA using enzymatic techniques remains a highly researched area. There is ongoing research into controlling the addition of nucleotides onto the forming DNA strand. The objective is to create the necessary sequence of DNA while making few errors.

In March 2026, the U.S. National Institutes of Health identified enzymatic processes for oligonucleotide and nucleic acid construct synthesis as an area of study. It highlighted the need for faster and more economical genomics tools (source: nih.gov). This research area is pertinent to developers looking for an alternative approach to the traditional DNA synthesis process.

The enzymatic DNA synthesis market consists of several technical methods. In TdT synthesis method, Terminal deoxynucleotidyl transferase is used to synthesize nucleotides without using a DNA template. In the polymerase synthesis method, enzymes are used to synthesize DNA through other processes. Researchers are still refining the sequence control process in these methods.

Longer DNA Sequences Draw Industry Attention

Short DNA strands are used in many laboratory procedures. Some research projects need much longer constructs, which can be more difficult to produce accurately. This has encouraged companies to develop methods for making complex DNA sequences.

Integrated DNA Technologies added to its synthetic biology portfolio through a collaboration with Ansa Biotechnologies in January 2026. These services include the Clonal DNA and XL Clonal DNA lines, available up to 50 kilobases. The products serve research that requires long DNA sequences. (source: ansabio.com)

The partnership also reflects a broader commercial approach. Established DNA suppliers can add specialized products through agreements with technology developers. This allows customers to access new types of DNA through existing supply channels.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: Enzymatic DNA Synthesis Market Report

Applications Span Research and Therapeutic Development

Gene and genome engineering is a major area of use for custom DNA. It accounted for an 18.50% share in 2025. Researchers need designed sequences to study genes and test changes to genetic material. Synthetic biology teams use them to build or modify biological systems.

Therapeutic development adds another area of demand. DNA synthesis supports research into gene-based treatments and DNA vaccines. It can also provide genetic material for work on other therapeutic platforms. The role of enzymatic synthesis depends on the product being developed and the DNA specifications required.

DNA data storage is at an earlier stage of development. The segment is projected to grow at an 39.58% CAGR. The DNA data storage approach encodes digital information in DNA sequences. Producing those sequences accurately and at a reasonable cost remains a key requirement. Enzymatic methods may offer another route to production if they can meet the needs of this application.

Regional Activity and Industry Competition

North America held the largest regional share of the enzymatic DNA synthesis market in 2025, accounting for 47.50% of revenue. The United States has an established biotechnology sector and a strong base of genomic research. Canada also contributes through its life sciences research activity.

Asia Pacific is forecast to grow at a CAGR of 29.50% during the forecast period. China, Japan, and South Korea have established biotechnology industries. India is also expanding its research and biomanufacturing base. Europe remains an important market due to its pharmaceutical sector and life sciences research institutions. Latin America and the Middle East & Africa are developing markets where access to specialized DNA services may affect adoption.

Competitive Landscape

Competition includes companies developing enzymatic synthesis methods and suppliers serving the wider DNA synthesis market. DNA Script SAS focuses on enzymatic oligonucleotide synthesis. Camena Bioscience Limited develops enzymatic gene synthesis technology. Ansa Biotechnologies works on long and complex DNA. Touchlight and 4basebio PLC use enzymatic processes to manufacture DNA products. Moligo Technologies AB focuses on long single-stranded DNA.

Other companies in the enzymatic DNA synthesis market include Molecular Assemblies, Inc., Codexis, Inc., Telesis Bio, Inc., Elegen Corporation, Evonetix Ltd., Kern Systems, Inc., GenScript Biotech Corporation, and Twist Bioscience Corporation. Their roles differ. Some develop synthesis technologies, while others supply related products or services.

Future Outlook

The next stage of development will depend on production performance. The process of enzyme engineering could be useful in increasing sequence precision. Automation could make it easier for researchers to control the DNA manufacturing process. Artificial intelligence could assist scientists in detecting potentially problematic sequences. Commercial use will depend on whether these advances can deliver consistent results at a competitive cost.

Enzymatic DNA Synthesis Market Segmentation

By Services: Oligonucleotide Synthesis | Gene Synthesis | Vaccine Development | Others

By Technology: TdT-based Enzymatic Synthesis | Polymerase-based Enzymatic Synthesis | Ligation-based Enzymatic Synthesis | Other Enzymatic Synthesis Technologies

By End Users: Pharmaceutical & Biotechnology Companies | Diagnostics & Genomics Companies | CROs & CDMOs | Academic & Research Institutions | Others

By Region: North America (U.S., Canada)| Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)| Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea, Rest of Asia Pacific)| Latin America (Brazil, Mexico, Argentina)| Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa, Rest of Middle East & Africa)